# Use of a Probiotic in the Treatment of Fibromyalgia (FIBROPROB)

> **NCT04435886** · NA · UNKNOWN · sponsor: **Biopolis S.L.** · enrollment: 50 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04435886
- **Lead sponsor:** Biopolis S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-02
- **Primary completion:** 2021-02-02
- **Final completion:** 2021-05-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435886, "Use of a Probiotic in the Treatment of Fibromyalgia (FIBROPROB)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04435886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*